Replies to post #115965 on Biotech Values

[MadCityCyclone]

Quiz—This NYT article on Big Pharma’s woes has a serious misstatement, one bad enough to be characterized as egregious:

http://www.nytimes.com/2011/03/07/business/07drug.html

What is it?


Merck stopped testing its top acquisition from its merger with Schering Plough, a blood thinner that caused dangerous amounts of bleeding.

[biomaven0]

Pfizer’s best asset, he said, is its $20 billion stockpile of cash.

I think it's more like $28 billion. I figure $8 billion light makes the "egregious" category. :)

Peter

[jbog]

I don't think I have to venture past the Headline itself:

Drug Firms Face Billions in Losses in ’11 as Patents End